Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/82294
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): Present and future |
Autor: | Peréz-Pérez, María-Jesús CSIC ORCID ; Priego, Eva María CSIC ORCID; Hernández, Ana-Isabel CSIC; Familiar, Olga CSIC; Camarasa Rius, María José CSIC ORCID; Negri, Ana; Gago, Federico CSIC ORCID; Balzarini, Jan | Fecha de publicación: | 2008 | Editor: | John Wiley & Sons | Citación: | Medicinal Research Reviews 28: 797- 820 (2008) | Resumen: | Human mitochondrial thymidine kinase (TK2) is a pyrimidine deoxynucleoside kinase (dNK) that catalyzes the phosphorylation of pyrimidine deoxynucleosides to their corresponding deoxynucleoside 5′-monophosphates by γ-phosphoryl transfer from ATP. In resting cells, TK2 is suggested to play a key role in the mitochondrial salvage pathway to provide pyrimidine nucleotides for mitochondrial DNA (mtDNA) synthesis and maintenance. However, recently the physiological role of TK2 turned out to have direct clinical relevance as well. Point mutations in the gene encoding TK2 have been correlated to mtDNA disorders in a heterogeneous group of patients suffering from the so-called mtDNA depletion syndrome (MDS). TK2 activity could also be involved in mitochondrial toxicity associated to prolonged treatment with antiviral nucleoside analogues like AZT and FIAU. Therefore, TK2 inhibitors can be considered as valuable tools to unravel the role of TK2 in the maintenance and homeostasis of mitochondrial nucleotide pools and mtDNA, and to clarify the contribution of TK2 activity to mitochondrial toxicity of certain antivirale. Highly selective TK-2 inhibitors having an acyclic nucleoside structure and efficiently discriminating between TK-2 and the closely related TK-1 have already been reported. It is actually unclear whether these agents efficiently reach the inner mitochondrial compartment. In the present review article, structural features of TK2, MDS-related mutations observed in TK2 and their role in MDS will be discussed. Also, an update on novel and selective TK2 inhibitors will be provided. © 2008 Wiley Periodicals, Inc. | URI: | http://hdl.handle.net/10261/82294 | DOI: | 10.1002/med.20124 | Identificadores: | doi: 10.1002/med.20124 issn: 0198-6325 e-issn: 1098-1128 |
Aparece en las colecciones: | (IQM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
3
checked on 12-mar-2024
SCOPUSTM
Citations
21
checked on 27-mar-2024
WEB OF SCIENCETM
Citations
19
checked on 29-feb-2024
Page view(s)
344
checked on 28-mar-2024
Download(s)
111
checked on 28-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.